Pfizer’s Eraxis Approved By The FDA

by Medindia Content Team on  February 22, 2006 at 4:20 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

Pfizer’s Eraxis Approved By The FDA
Pfizer Inc announced the approval of a new antifungal drug, for the treatment of bloodstream infection by the FDA. The new drug called Eraxis, is indicated in the treatment of candidemia, a hospital acquired fatal blood infection.

The improved performance of Eraxis compared to Diflucan, a currently employed anti-fungal treatment is said to have supported the approval. The drug can also be used in the treatment of infections caused by Candida (a fungus), intra-abdominal abscesses, fungal infection of the esophagus and peritonitis.

The acquisition of Vicuron Pharmaceuticals Inc. by Pfizer in September is said to have set stage for acquiring Eraxis. The company's share value in the afternoon fell down to 18% ($25.65) on the New York Stock Exchange.


Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive